SEC Form 4 · accession 0002014639-26-000011
Indivior Pharmaceuticals, Inc. · INDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christian Heidbreder
Officer — Chief Scientific Officer
Period of report
Jul 10, 2026
Accepted (ET)
Jul 13, 2026 · 4:31 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001625297
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 10, 2026 | S | 18,586 | $41.14 | D | 209,337 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2026.